“…genes involved in metabolic diseases, oncogenes, etc. Because of its simplicity and dependability, the method has been used for routine screening of defects of the PI-gene [Johnson et al, 1991;Dubel et al, 1991]. However, these setups did not detect mutations in the splice junction sites, which frequently occur in metabolic diseases such as phenylketonuria (PKU) [Michiels et al, 1996[Michiels et al, , 1998] but up to now only one has been detected in PI deficiency [Laubach et al, 1993].…”